A 58-year-old with diabetes and CKD G3a/A3 is on ACE inhibitor and SGLT2 inhibitor with controlled BP. Which additional therapy reduces CKD progressio...

Question

A 58-year-old with diabetes and CKD G3a/A3 is on ACE inhibitor and SGLT2 inhibitor with controlled BP. Which additional therapy reduces CKD progression and cardiovascular events in diabetic CKD with persistent albuminuria?

Accepted Answer

Add nonsteroidal mineralocorticoid receptor antagonist (finerenone)

Answer

Start NSAID for proteinuria

Answer

Stop ACE inhibitor to avoid hyperkalemia

Answer

Add loop diuretic chronically for renoprotection

Answer

No additional therapy is supported

us-abim MCQ (SBA): Diabetic CKD-Finerenone

A 58-year-old with diabetes and CKD G3a/A3 is on ACE inhibitor and SGLT2 inhibitor with controlled BP. Which additional therapy reduces CKD progression and cardiovascular events in diabetic CKD with persistent albuminuria?